CD123/CD33 dual-antibody modified liposomes effectively target acute myeloid leukemia cells and reduce antigen-negative escape-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD123/CD33 dual-antibody modified liposomes effectively target acute myeloid leukemia cells and reduce antigen-negative escape

Published:2019-09 Issue: Volume:568 Page:118518
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Sun Shili,Zou Huixi,Li Lin,Liu Qi,Ding Ning,Zeng Lili,Li Hui,Mao Shengjun

Funder

National Natural Science Foundation of China

Key Research and Development Projects of SichuanDepartment ofScience and Technology

Sichuan Youth Science and Technology Innovation Research Team Funding

Sichuan Science and Technology Program

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles;Benfer;Eur. J. Pharm. Biopharm.,2012

2. A proteomics and transcriptomics approach to identify leukemic stem cell (LSC) markers;Bonardi;Mol. Cell. Proteomics,2013

3. Dual-targeting triplebody 33–16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells;Braciak;Oncoimmunology,2018

4. Advances in treatment formulations for acute myeloid leukemia;Briot;Drug Discov. Today,2018

5. Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignancies;Burt;Hum. Vaccine Immunother.,2019

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of CD33-Targeted Dual Drug-Loaded Nanoparticles for the Treatment of Pediatric Acute Myeloid Leukemia;Biomacromolecules;2024-09-05

2. Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia;Small;2024-06-27

3. Engineering aspects of lipid-based delivery systems: In vivo gene delivery, safety criteria, and translation strategies;Biotechnology Advances;2024-05

4. Dual-targeting CD33/CD123 NANOBODY T-cell engager with potent anti-AML activity and good safety profile;Blood Advances;2024-04-26

5. Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology;European Journal of Medical Research;2024-04-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3